Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approach.

Advanced human malignancies cannot be permanently cured by adoptive transfer of autologous lymphokine-activated killer (LAK) cells. Moreover, administration of high doses of IL-2 to maintain LAK activity in vivo is associated with severe toxicity. In this study, we tested the anti-tumor efficacy of...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Cesano, A, Visonneau, S, Cioé, L, Clark, S C, Rovera, G, Santoli, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1994
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC295167/
https://ncbi.nlm.nih.gov/pubmed/8083348
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak